Thrombolytic and Anticoagulant Therapy for Pulmonary Embolism with High and Intermendiate Risk of Early Death. Part 3. An Effect on Pulmonary Perfusion with High and Intermediate Risk of Early Death

Background The advantage of thrombolytic therapy (TLT) over anticoagulant therapy(ACT) in patients with a high risk of early death (hemodynamic disorders) in acute pulmonary embolism is considered proven. But the advantage of thrombolytic therapy over anticoagulant therapy remains uncertain in patie...

Descripción completa

Detalles Bibliográficos

Autores principales:	O. V. Nikitina, I. P. Mikhailov, N. Y. Kudryashova, E. V. Migunova, A. G. Dorfman, V. I. Avfukov
Formato:	Artigo
Lenguaje:	Russo
Publicado:	Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department 2018-11-01
Colección:	Неотложная медицинская помощь
Materias:	pulmonary embolism thrombolytic therapy anticoagulant therapy perfusion scintigraphy pulmonary perfusion deficiency pulmonary hypertension intermediate risk of early death
Acceso en línea:	https://www.jnmp.ru/jour/article/view/501
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!